Inhibikase Therapeutics Inc (IKT)

Cash & Short-Term Investments

$159.02M

Quarterly · Period ending: · USD

IKT logo

IKT Cash & Short-Term Investments

Latest reported$159.02M
IKT Quarterly Cash & Short-Term Investments ($12.04K → $159.02M)
High-resolution chart · PNG

IKT cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
159,018,847
170,368,745
178,764,028
77,322,216
87,665,769
93,180,291
97,543,527
3,243,646
7,940,014
9,749,355
13,252,052
16,831,569
20,935,016
25,718,167
23,050,173
26,534,208
32,212,276
36,611,167
40,750,133
44,845,950
46,836,556
9,609,631
13,953,513
16,168
7,785
13,145
18,457
379,557
379,557
65,179
16,665
12,036
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.